Author: Belal N Alshaikh (1)
Effect of Oral Lipid Matrix Supplement on Fat Absorption in Cystic Fibrosis: A Randomized Placebo-Controlled Trial.J Pediatr Gastroenterol Nutr 2016 Dec;63(6):676-680Virginia A Stallings, Joan I Schall, Asim Maqbool, Maria R Mascarenhas, Belal N Alshaikh, Kelly A Dougherty, Kevin Hommel, Jamie Ryan, Okan U Elci, Walter A Shaw
Pancreatic enzyme therapy does not normalize dietary fat absorption in patients with cystic fibrosis and pancreatic insufficiency. Efficacy of LYM-X-SORB (LXS), an easily absorbable lipid matrix that enhances fat absorption, was evaluated in a 12-month randomized, double-blinded, placebo-controlled trial with plasma fatty acids (FA) and coefficient of fat absorption (CFA) outcomes. A total of 110 subjects (age 10.
View Full Text PDF Listings View primary source full text article PDFs.